The role of Wnt signaling in the development of alzheimer's disease: A potential therapeutic target?

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Wan, Wenbin ^a   Xia, Shijin ^b   Kalionis, Bill ^c   Liu, Lumei ^a   Li, Yaming ^a  

^a HUADONG HOSPITAL AFFILIATED TO FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DICKKOPF 1 PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; WNT PROTEIN; AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; BRAIN PROTECTION; BRAIN REGION; CENTRAL NERVOUS SYSTEM; DISEASE COURSE; EMBRYO DEVELOPMENT; ENZYME INHIBITION; GENE OVEREXPRESSION; HUMAN; NERVE GROWTH; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; REVIEW; WNT SIGNALING PATHWAY; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; MOLECULARLY TARGETED THERAPY; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR TARGETED THERAPY; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84901760036     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/301575     Document Type: Review

References (93)

1. Kim W., Kim M., Jho E. H., Wnt/beta-catenin signalling: from plasma membrane to nucleus. The Biochemical Journal 2013 450 1 9 21
2. Inestrosa N. C., Montecinos-Oliva C., Fuenzalida M., Wnt signaling: role in Alzheimer disease and schizophrenia. Journal of Neuroimmune Pharmacology 2012 7 4 788 807
3. MacDonald B. T., Tamai K., He X., Wnt/beta-catenin signaling: components, mechanisms, and diseases. Developmental Cell 2009 17 1 9 26 2-s2.0-67650230896 10.1016/j.devcel.2009.06.016
4. Clevers H., Colon cancer-understanding how NSAIDs work. The New England Journal of Medicine 2006 354 7 761 763 2-s2.0-32644470964 10.1056/NEJMcibr055457 (Pubitemid 43247150)
5. Rosso S. B., Inestrosa N. C., WNT signaling in neuronal maturation and synaptogenesis. Frontiers in Cellular Neuroscience 2013 7 article 103
6. Ciani L., Salinas P. C., WNTs in the vertebrate nervous system: from patterning to neuronal connectivity. Nature Reviews Neuroscience 2005 6 5 351 362 2-s2.0-17844366846 10.1038/nrn1665 (Pubitemid 40593481)
7. Toledo E. M., Colombres M., Inestrosa N. C., Wnt signaling in neuroprotection and stem cell differentiation. Progress in Neurobiology 2008 86 3 281 296 2-s2.0-48749133346 10.1016/j.pneurobio.2008.08.001
8. Inestrosa N. C., Arenas E., Emerging roles of Wnts in the adult nervous system. Nature Reviews Neuroscience 2010 11 2 77 86 2-s2.0-75549087261 10.1038/nrn2755
9. Mayeux R., Stern Y., Epidemiology of Alzheimer disease. Cold Spring Harbor Perspectives in Medicine 2012 2 8 10.1101/cshperspect.a006239
10. Mattson M. P., Pathways towards and away from Alzheimer's disease. Nature 2004 430 7000 631 639 2-s2.0-3943092621 10.1038/nature02621 (Pubitemid 39061671)
11. Buée L., Troquier L., Burnouf S., Belarbi K., Van Der Jeugd A., Ahmed T., Fernandez-Gomez F., Caillierez R., Grosjean M., Begard S., Barbot B., Demeyer D., Obriot H., Brion I., Buée-Scherrer V., Maurage C., Balschun D., D'Hooge R., Hamdane M., Blum D., Sergeant N., From tau phosphorylation to tau aggregation: what about neuronal death? Biochemical Society Transactions 2010 38 4 967 972 2-s2.0-77955978487 10.1042/BST0380967
12. Hartz A. M. S., Bauer B., Soldner E. L. B., Wolf A., Boy S., Backhaus R., Mihaljevic I., Bogdahn U., Klünemann H. H., Schuierer G., Schlachetzki F., Amyloid- β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke 2012 43 2 514 523 2-s2.0-84856429045 10.1161/STROKEAHA.111.627562
13. Wan W., Chen H., Li Y., The potential mechanisms of Abeta-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease. The International Journal of Neuroscience 2014 124 2 75 81
14. 2+-calcineurin signaling. The Journal of Neuroscience 2012 32 26 8845 8854
15. 2+ in mitochondrial dynamics. Frontiers in Cellular Neuroscience 2013 7 article 97
16. Thies W., Bleiler L., 2011 Alzheimer's disease facts and figures. Alzheimer's and Dementia 2011 7 2 208 244 2-s2.0-79952730699 10.1016/j.jalz.2011.02.004
17. Mendoza J., Sekiya M., Taniguchi T., Iijima K. M., Wang R., Ando K., Global analysis of phosphorylation of tau by the checkpoint kinases Chk1 and Chk2 in vitro. Journal of Proteome Research 2013 12 6 2654 2665
18. Folwell J., Cowan C. M., Ubhi K. K., Shiabh H., Newman T. A., Shepherd D., Mudher A., A β exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease. Experimental Neurology 2010 223 2 401 409 2-s2.0-77952549902 10.1016/j.expneurol.2009.09.014
19. Vargas J. Y., Fuenzalida M., Inestrosa N. C., In vivo activation of Wnt signaling pathway enhances cognitive function of adult mice and reverses cognitive deficits in an Alzheimer's disease model. The Journal of Neuroscience 2014 34 6 2191 2202
20. Clevers H., Nusse R., Wnt/beta-catenin signaling and disease. Cell 2012 149 6 1192 1205
21. Alvarez A. R., Godoy J. A., Mullendorff K., Olivares G. H., Bronfman M., Inestrosa N. C., Wnt-3a overcomes β -amyloid toxicity in rat hippocampal neurons. Experimental Cell Research 2004 297 1 186 196 2-s2.0-2942578107 10.1016/j.yexcr.2004.02.028 (Pubitemid 38759572)
22. Rosi M. C., Luccarini I., Grossi C., Fiorentini A., Spillantini M. G., Prisco A., Scali C., Gianfriddo M., Caricasole A., Terstappen G. C., Casamenti F., Increased dickkopf-1 expression in transgenic mouse models of neurodegenerative disease. Journal of Neurochemistry 2010 112 6 1539 1551 2-s2.0-77349095896 10.1111/j.1471-4159.2009.06566.x
23. Purro S. A., Dickins E. M., Salinas P. C., The secreted Wnt antagonist dickkopf-1 is required for amyloid β -mediated synaptic loss. The Journal of Neuroscience 2012 32 10 3492 3498 2-s2.0-84857870160 10.1523/JNEUROSCI.4562- 11.2012
24. Maguschak K. A., Ressler K. J., A role for WNT/beta-catenin signaling in the neural mechanisms of behavior. Journal of Neuroimmune Pharmacology 2012 7 4 763 773
25. Shruster A., Eldar-Finkelman H., Melamed E., Offen D., Wnt signaling pathway overcomes the disruption of neuronal differentiation of neural progenitor cells induced by oligomeric amyloid β -peptide. Journal of Neurochemistry 2011 116 4 522 529 2-s2.0-79551647053 10.1111/j.1471-4159.2010. 07131.x
26. Angers S., Moon R. T., Proximal events in Wnt signal transduction. Nature Reviews Molecular Cell Biology 2009 10 7 468 477 2-s2.0-67649470380 10.1038/nrm2717
27. van Amerongen R., Nusse R., Towards an integrated view of Wnt signaling in development. Development 2009 136 19 3205 3214 2-s2.0-70349932747 10.1242/dev.033910
28. Port F., Basler K., Wnt trafficking: new insights into Wnt maturation, secretion and spreading. Traffic 2010 11 10 1265 1271 2-s2.0-77956495200 10.1111/j.1600-0854.2010.01076.x
29. Gordon M. D., Nusse R., Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. The Journal of Biological Chemistry 2006 281 32 22429 22433 2-s2.0-33747339465 10.1074/jbc.R600015200
30. Salic A., Lee E., Mayer L., Kirschner M. W., Control of β -catenin stability: reconstitution of the cytoplasmic steps of the Wnt pathway in Xenopus egg extracts. Molecular Cell 2000 5 3 523 532 2-s2.0-0033714885
31. Price M. A., CKI, there's more than one: casein kinase I family members in Wnt and Hedgehog signaling. Genes and Development 2006 20 4 399 410 2-s2.0-32644451364
32. Wu D., Pan W., GSK3: a multifaceted kinase in Wnt signaling. Trends in Biochemical Sciences 2010 35 3 161 168 2-s2.0-77649129121 10.1016/j.tibs.2009. 10.002
33. Freese J. L., Pino D., Pleasure S. J., Wnt signaling in development and disease. Neurobiology of Disease 2010 38 2 148 153 2-s2.0-77951207867 10.1016/j.nbd.2009.09.003
34. Liebner S., Corada M., Bangsow T., Babbage J., Taddei A., Czupalla C. J., Reis M., Felici A., Wolburg H., Fruttiger M., Taketo M. M., Von Melchner H., Plate K. H., Gerhardt H., Dejana E., Wnt/ β -catenin signaling controls development of the blood-brain barrier. Journal of Cell Biology 2008 183 3 409 417 2-s2.0-56149124382 10.1083/jcb.200806024
35. Scott E. L., Brann D. W., Estrogen regulation of Dkk1 and Wnt/beta-catenin signaling in neurodegenerative disease. Brain Research 2013 1514 63 74
36. Oliva C. A., Vargas J. Y., Inestrosa N. C., Wnt signaling: role in LTP, neural networks and memory. Ageing Research Reviews 2013 12 3 786 800
37. Rosso S. B., Sussman D., Wynshaw-Boris A., Salinas P. C., Wnt signaling through dishevelled, Rac and JNK regulates dendritic development. Nature Neuroscience 2005 8 1 34 42 2-s2.0-16644381829 10.1038/nn1374 (Pubitemid 41236729)
38. Yamanaka H., Moriguchi T., Masuyama N., Kusakabe M., Hanafusa H., Takada R., Takada S., Nishida E., JNK functions in the non-canonical Wnt pathway to regulate convergent extension movements in vertebrates. EMBO Reports 2002 3 1 69 75 2-s2.0-0036166289 10.1093/embo-reports/kvf008 (Pubitemid 34144818)
39. Huelsken J., Held W., Canonical Wnt signalling plays essential roles. European Journal of Immunology 2009 39 12 3582 3584 2-s2.0-73949154449
40. Kohn A. D., Moon R. T., Wnt and calcium signaling: β -catenin-independent pathways. Cell Calcium 2005 38 3-4 439 446 2-s2.0-24644499046 10.1016/j.ceca.2005.06.022 (Pubitemid 41283282)
41. Montcouquiol M., Crenshaw E. B. III, Kelley M. W., Noncanonical Wnt signaling and neural polarity. Annual Review of Neuroscience 2006 29 363 386 2-s2.0-33748362173 10.1146/annurev.neuro.29.051605.112933 (Pubitemid 44476850)
42. Farías G. G., Godoy J. A., Cerpa W., Varela-Nallar L., Inestrosa N. C., Wnt signaling modulates pre- and postsynaptic maturation: therapeutic considerations. Developmental Dynamics 2010 239 1 94 101 2-s2.0-73949158445 10.1002/dvdy.22065
43. van Amerongen R., Mikels A., Nusse R., Alternative wnt signaling is initiated by distinct receptors. Science Signaling 2008 1 35 re9 2-s2.0-55749102279 10.1126/scisignal.135re9
44. Gao C., Chen Y., Dishevelled: the hub of Wnt signaling. Cellular Signalling 2010 22 5 717 727 2-s2.0-77951888466
45. Bilić J., Huang Y., Davidson G., Zimmermann T., Cruciat C., Bienz M., Niehrs C., Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. Science 2007 316 5831 1619 1622 2-s2.0-34250827150 10.1126/science.1137065 (Pubitemid 46982035)
46. Logan C. Y., Nusse R., The Wnt signaling pathway in development and disease. Annual Review of Cell and Developmental Biology 2004 20 781 810 2-s2.0-8444251784 10.1146/annurev.cellbio.20.010403.113126 (Pubitemid 39488658)
47. Salinas P. C., Zou Y., Wnt signaling in neural circuit assembly. Annual Review of Neuroscience 2008 31 339 358 2-s2.0-48249110960 10.1146/annurev.neuro. 31.060407.125649
48. Purro S. A., Ciani L., Hoyos-Flight M., Stamatakou E., Siomou E., Salinas P. C., Wnt regulates axon behavior through changes in microtubule growth directionality: A new role for adenomatous polyposis coli. The Journal of Neuroscience 2008 28 34 8644 8654 2-s2.0-51649085383 10.1523/JNEUROSCI.2320-08. 2008
49. Lucas F. R., Salinas P. C., WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons. Developmental Biology 1997 192 1 31 44 2-s2.0-0031469645 10.1006/dbio.1997.8734 (Pubitemid 28015644)
50. Cerpa W., Godoy J. A., Alfaro I., Farías G. G., Metcalfe M. J., Fuentealba R., Bonansco C., Inestrosa N. C., Wnt-7a modulates the synaptic vesicle cycle and synaptic transmission in hippocampal neurons. The Journal of Biological Chemistry 2008 283 9 5918 5927 2-s2.0-41949142202 10.1074/jbc.M705943200
51. Cerpa W., Gambrill A., Inestrosa N. C., Barria A., Regulation of NMDA-receptor synaptic transmission by Wnt signaling. The Journal of Neuroscience 2011 31 26 9466 9471 2-s2.0-79959960791 10.1523/JNEUROSCI.6311-10. 2011
52. Varela-Nallar L., Alfaro I. E., Serrano F. G., Parodi J., Inestrosa N. C., Wingless-type family member 5A (Wnt-5a) stimulates synaptic differentiation and function of glutamatergic synapses. Proceedings of the National Academy of Sciences of the United States of America 2010 107 49 21164 21169 2-s2.0-78650506425 10.1073/pnas.1010011107
53. Bodmer D., Levine-Wilkinson S., Richmond A., Hirsh S., Kuruvilla R., Wnt5a mediates nerve growth factor-dependent axonal branching and growth in developing sympathetic neurons. The Journal of Neuroscience 2009 29 23 7569 7581 2-s2.0-67049162113 10.1523/JNEUROSCI.1445-09.2009
54. Hall A. C., Lucas F. R., Salinas P. C., Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling. Cell 2000 100 5 525 535 2-s2.0-0034598921
55. Wayman G. A., Impey S., Marks D., Saneyoshi T., Grant W. F., Derkach V., Soderling T. R., Activity-dependent dendritic arborization mediated by CaM-kinase I activation and enhanced CREB-dependent transcription of Wnt-2. Neuron 2006 50 6 897 909 2-s2.0-33744900895 10.1016/j.neuron.2006.05.008 (Pubitemid 43850689)
56. Fan S., Ramirez S. H., Garcia T. M., Dewhurst S., Dishevelled promotes neurite outgrowth in neuronal differentiating neuroblastoma 2A cells, via a DIX-domain dependent pathway. Molecular Brain Research 2004 132 1 38 50 2-s2.0-8844252388 10.1016/j.molbrainres.2004.09.003 (Pubitemid 39531350)
57. Ciani L., Krylova O., Smalley M. J., Dale T. C., Salinas P. C., A divergent canonical WNT-signaling pathway regulates microtubule dynamics: dishevelled signals locally to stabilize microtubules. Journal of Cell Biology 2004 164 2 243 253 2-s2.0-1642499116 10.1083/jcb.200309096 (Pubitemid 38133944)
58. Yu X., Malenka R. C., β -catenin is critical for dendritic morphogenesis. Nature Neuroscience 2003 6 11 1169 1177 2-s2.0-0242384747 10.1038/nn1132 (Pubitemid 37346037)
59. Palop J. J., Mucke L., Amyloid- Β -induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nature Neuroscience 2010 13 7 812 818 2-s2.0-77954132249 10.1038/nn.2583
60. Shankar G. M., Li S., Mehta T. H., Garcia-Munoz A., Shepardson N. E., Smith I., Brett F. M., Farrell M. A., Rowan M. J., Lemere C. A., Regan C. M., Walsh D. M., Sabatini B. L., Selkoe D. J., Amyloid- β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nature Medicine 2008 14 8 837 842 2-s2.0-49149124343 10.1038/nm1782
61. Cerpa W., Farías G. G., Godoy J. A., Fuenzalida M., Bonansco C., Inestrosa N. C., Wnt-5a occludes A β oligomer-induced depression of glutamatergic transmission in hippocampal neurons. Molecular Neurodegeneration 2010 5 1, article 3 2-s2.0-77249117920 10.1186/1750-1326-5-3
62. Kania K. D., Wijesuriya H. C., Hladky S. B., Barrand M. A., Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells. Brain Research 2011 1418 1 11 2-s2.0-80053386106 10.1016/j.brainres.2011. 08.044
63. Caraci F., Busceti C., Biagioni F., Aronica E., Mastroiacovo F., Cappuccio I., Battaglia G., Bruno V., Caricasole A., Copani A., Nicoletti F., The Wnt antagonist, Dickkopf-1, as a target for the treatment of neurodegenerative disorders. Neurochemical Research 2008 33 12 2401 2406 2-s2.0-56349085908 10.1007/s11064-008-9710-0
64. Hooper C., Killick R., Lovestone S., The GSK3 hypothesis of Alzheimer's disease. Journal of Neurochemistry 2008 104 6 1433 1439 2-s2.0-39849110726 10.1111/j.1471-4159.2007.05194.x (Pubitemid 351316776)
65. Killick R., Ribe E. M., Al-Shawi R., Clusterin regulates beta-amyloid toxicity via Dickkopf-1-driven induction of the Wnt-PCP-JNK pathway. Molecular Psychiatry 2014 19 1 88 98
66. Hooper C., Markevich V., Plattner F., Killick R., Schofield E., Engel T., Hernandez F., Anderton B., Rosenblum K., Bliss T., Cooke S. F., Avila J., Lucas J. J., Giese K. P., Stephenson J., Lovestone S., Glycogen synthase kinase-3 inhibition is integral to long-term potentiation. European Journal of Neuroscience 2007 25 1 81 86 2-s2.0-33846259727 10.1111/j.1460-9568.2006.05245.x (Pubitemid 46096224)
67. Li X. H., Du L. L., Cheng X. S., Glycation exacerbates the neuronal toxicity of beta-amyloid. Cell Death & Disease 2013 4 e673
68. Phiel C. J., Wilson C. A., Lee V. M.-Y., Klein P. S., GSK-3 α regulates production of Alzheimer's disease amyloid- β peptides. Nature 2003 423 6938 435 439 2-s2.0-0038187674 10.1038/nature01640 (Pubitemid 36626994)
69. Inestrosa N. C., Varela-Nallar L., Wnt signaling in the nervous system and in Alzheimer's disease. Journal of Molecular Cell Biology 2014 6 1 64 74
70. Quintanilla R. A., Muñoz F. J., Metcalfe M. J., Hitschfeld M., Olivares G., Godoy J. A., Inestrosa N. C., Trolox and 17 β -estradiol protect against amyloid β -peptide neurotoxicity by a mechanism that involves modulation of the Wnt signaling pathway. The Journal of Biological Chemistry 2005 280 12 11615 11625 2-s2.0-15744368753 10.1074/jbc.M411936200 (Pubitemid 40418475)
71. Caricasole A., Copani A., Caraci F., Aronica E., Rozemuller A. J., Caruso A., Storto M., Gaviraghi G., Terstappen G. C., Nicoletti F., Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain. The Journal of Neuroscience 2004 24 26 6021 6027 2-s2.0-3042834662 10.1523/JNEUROSCI.1381-04.2004 (Pubitemid 38859398)
72. Lacor P. N., Buniel M. C., Furlow P. W., Clemente A. S., Velasco P. T., Wood M., Viola K. L., Klein W. L., A β oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. The Journal of Neuroscience 2007 27 4 796 807 2-s2.0-33846633336 10.1523/JNEUROSCI.3501-06.2007 (Pubitemid 46174498)
73. Caruso A., Motolese M., Iacovelli L., Caraci F., Copani A., Nicoletti F., Terstappen G. C., Gaviraghi G., Caricasole A., Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells. Journal of Neurochemistry 2006 98 2 364 371 2-s2.0-33746543634 10.1111/j.1471-4159.2006.03867.x (Pubitemid 44133142)
74. Donahue J. E., Johanson C. E., Apolipoprotein E, amyloid- β and blood-brain barrier permeability in Alzheimer disease. Journal of Neuropathology and Experimental Neurology 2008 67 4 261 270 2-s2.0-41949101345 10.1097/NEN.0b013e31816a0dc8 (Pubitemid 351507482)
75. de Ferrari G. V., Papassotiropoulos A., Biechele T., De-Vrieze F. W., Avila M. E., Major M. B., Myers A., Sáez K., Henríquez J. P., Zhao A., Axel Wollmer M., Nitsch R. M., Hock C., Morris C. M., Hardy J., Moon R. T., Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2007 104 22 9434 9439 2-s2.0-34547191230 10.1073/pnas.0603523104 (Pubitemid 47185797)
76. Boonen R. A. C. M., van Tijn P., Zivkovic D., Wnt signaling in Alzheimer's disease: up or down, that is the question. Ageing Research Reviews 2009 8 2 71 82 2-s2.0-60949111784 10.1016/j.arr.2008.11.003
77. Chacón M. A., Varela-Nallar L., Inestrosa N. C., Frizzled-1 is involved in the neuroprotective effect of Wnt3a against A β oligomers. Journal of Cellular Physiology 2008 217 1 215 227 2-s2.0-49649088889 10.1002/jcp.21497
78. Kawamoto E. M., Gleichmann M., Yshii L. M., de Sá Lima L., Mattson M. P., Scavone C., Effect of activation of canonical Wnt signaling by the Wnt-3a protein on the susceptibility of PC12 cells to oxidative and apoptotic insults. Brazilian Journal of Medical and Biological Research 2012 45 1 58 67 2-s2.0-84855909434 10.1590/S0100-879X2011007500157
79. Mao B., Wu W., Li Y., Hoppe D., Stannek P., Glinka A., Niehrs C., LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 2001 411 6835 321 325 2-s2.0-0035902050 10.1038/35077108 (Pubitemid 32467039)
80. Fiorentini A., Rosi M. C., Grossi C., Luccarini I., Casamenti F., Lithium improves hippocampal neurogenesis, neuropathology and cognitive functions in APP mice. PLoS ONE 2010 5 12 2-s2.0-78650904823 10.1371/journal.pone.0014382 e14382
81. Wexler E. M., Geschwind D. H., Palmer T. D., Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation. Molecular Psychiatry 2008 13 3 285 292 2-s2.0-39449117350 10.1038/sj.mp.4002093 (Pubitemid 351272655)
82. Zhang X., Yin W., Shi X., Li Y., Curcumin activates Wnt/ β -catenin signaling pathway through inhibiting the activity of GSK-3 β in APPswe transfected SY5Y cells. European Journal of Pharmaceutical Sciences 2011 42 5 540 546 2-s2.0-79954628955 10.1016/j.ejps.2011.02.009
83. Farías G. G., Godoy J. A., Hernández F., Avila J., Fisher A., Inestrosa N. C., M1 muscarinic receptor activation protects neurons from β -amyloid toxicity. A role for Wnt signaling pathway. Neurobiology of Disease 2004 17 2 337 348 2-s2.0-5144234244 10.1016/j.nbd.2004.07.016 (Pubitemid 39345789)
84. Caccamo A., Oddo S., Billings L. M., Green K. N., Martinez-Coria H., Fisher A., LaFerla F. M., M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 2006 49 5 671 682 2-s2.0-33344458827 10.1016/j.neuron.2006.01.020 (Pubitemid 43290127)
85. Dinamarca M. C., Sagal J. P., Quintanilla R. A., Godoy J. A., Arrzola M. S., Inestrosa N. C., Amyloid- β -acetylcholinesterase complexes potentiate neurodegenerative changes induced by the A peptide. Implications for the pathogenesis of Alzheimer's disease. Molecular Neurodegeneration 2010 5 4, article 4 2-s2.0-77249136019
86. Iozzi S., Remelli R., Lelli B., Functional characterization of a small-molecule inhibitor of the DKK1-LRP6 interaction. ISRN Molecular Biology 2012 2012 9 823875 10.5402/2012/823875
87. Zhang Y., Wang Y., Li X., Zhang J., Mao J., Li Z., Zheng J., Li L., Harris S., Wu D., The LRP5 high-bone-mass G171V mutation disrupts LRP5 interaction with Mesd. Molecular and Cellular Biology 2004 24 11 4677 4684 2-s2.0-2442656675 10.1128/MCB.24.11.4677-4684.2004 (Pubitemid 38668035)
88. Inestrosa N. C., Varela-Nallar L., Grabowski C. P., Colombres M., Synaptotoxicity in Alzheimer's disease: the Wnt signaling pathway as a molecular target. IUBMB Life 2007 59 4-5 316 321 2-s2.0-34248570158 10.1080/ 15216540701242490 (Pubitemid 46763756)
89. Wang C., Zheng W., Wang T., Xie J., Wang S., Zhao B., Teng W., Wang Z., Huperzine a activates Wnt/ Β -catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model. Neuropsychopharmacology 2011 36 5 1073 1089 2-s2.0-79952756491 10.1038/npp.2010.245
90. Farías G. G., Godoy J. A., Vázquez M. C., Adani R., Meshulam H., Avila J., Amitai G., Inestrosa N. C., The anti-inflammatory and cholinesterase inhibitor bifunctional compound IBU-PO protects from β -amyloid neurotoxicity by acting on Wnt signaling components. Neurobiology of Disease 2005 18 1 176 183 2-s2.0-11844285723 10.1016/j.nbd.2004.09.012 (Pubitemid 40092907)
91. Inestrosa N. C., Godoy J. A., Quintanilla R. A., Koenig C. S., Bronfman M., Peroxisome proliferator-activated receptor γ is expressed in hippocampal neurons and its activation prevents β -amyloid neurodegeneration: role of Wnt signaling. Experimental Cell Research 2005 304 1 91 104 2-s2.0-13644271368 10.1016/j.yexcr.2004.09.032 (Pubitemid 40227422)
92. Inestrosa N. C., Godoy J. A., Vargas J. Y., Nicotine prevents synaptic impairment induced by amyloid-beta oligomers through alpha7-nicotinic acetylcholine receptor activation. Neuromolecular Medicine 2013 15 3 549 569
93. Dinamarca M. C., Colombres M., Cerpa W., Bonansco C., Inestrosa N. C., β -amyloid oligomers affect the structure and function of the postsynaptic region: role of the Wnt signaling pathway. Neurodegenerative Diseases 2008 5 3-4 149 152 2-s2.0-40449128901 10.1159/000113687 (Pubitemid 351347835)